These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10526598

  • 21. Contrasting patterns of response to lamivudine monotherapy in chronic hepatitis B patients.
    Wolters LM, van Nunen AB, Niesters HG, de Man RA.
    Scand J Gastroenterol Suppl; 2000; (232):74-8. PubMed ID: 11232497
    [Abstract] [Full Text] [Related]

  • 22. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.
    Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
    [Abstract] [Full Text] [Related]

  • 23. Potential and limitations of lamivudine monotherapy in chronic hepatitis B: evidence from genotyping.
    Kennedy PT, Phillips N, Chandrasekhar J, Jacobs R, Jacobs M, Dusheiko G.
    Liver Int; 2008 May; 28(5):699-704. PubMed ID: 18433396
    [Abstract] [Full Text] [Related]

  • 24. [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication].
    Song JW, Zhang G, Lin JG, Tang WX, Lin JS.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):593-6. PubMed ID: 15504288
    [Abstract] [Full Text] [Related]

  • 25. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 26. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M, Colombo M, Aroldi A, Lunghi G, Manenti E, Ponticelli C, Lampertico P.
    Antivir Ther; 2005 Jul 10; 10(6):709-13. PubMed ID: 16218169
    [Abstract] [Full Text] [Related]

  • 27. [Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma].
    Musch E, Malek M, Chrissafidou A.
    Z Gastroenterol; 2003 May 10; 41(5):425-8. PubMed ID: 12772056
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Chronic hepatitis B virus infection].
    Trifan A, Stanciu C.
    Rev Med Chir Soc Med Nat Iasi; 2003 May 10; 107(1):19-27. PubMed ID: 14755965
    [Abstract] [Full Text] [Related]

  • 30. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
    Wakui Y, Inoue J, Ueno Y, Fukushima K, Kondo Y, Kakazu E, Obara N, Kimura O, Shimosegawa T.
    Biochem Biophys Res Commun; 2010 May 28; 396(2):508-14. PubMed ID: 20430009
    [Abstract] [Full Text] [Related]

  • 31. Therapy of chronic hepatitis B: today and tomorrow.
    Trifan A, Stanciu C.
    Rev Med Chir Soc Med Nat Iasi; 2003 May 28; 107(4):689-98. PubMed ID: 14756005
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Nucleoside analogues for chronic hepatitis B.
    Wolters LM, Niesters HG, de Man RA.
    Eur J Gastroenterol Hepatol; 2001 Dec 28; 13(12):1499-506. PubMed ID: 11742201
    [Abstract] [Full Text] [Related]

  • 35. Genetic variability of hepatitis B virus and response to antiviral treatments: searching for a bigger picture.
    Yuen LK, Locarnini SA.
    J Hepatol; 2009 Mar 28; 50(3):445-8. PubMed ID: 19152982
    [No Abstract] [Full Text] [Related]

  • 36. Experience with lamivudine against hepatitis B virus.
    Jaeckel E, Manns MP.
    Intervirology; 1997 Mar 28; 40(5-6):322-36. PubMed ID: 9675637
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.